Cytokinesis cycle protein 45 (CDC45) was thought to be associated with tumorigenesis, and its low proteomic levels were associated with poor prognosis in HCC patients, suggesting that CDC45 may be a novel prognostic marker for HCC (Yang et al., 2021). The gene discussed is CDC45; the disease is hepatocellular carcinoma.